Physician profile
Sama Carley
NPI 1487018263
$3,121.60
in general payments reported to CMS, 2019-2025
16 companies · $1,026 in 2025
The $1,026 reported for 2025 was more than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2021: $121 · 2023: $1,041 · 2024: $809 · 2025: $1,026.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,903 · Long Term Medical Supply Or Device Loan: $774 · Education: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,903.12 |
| Long Term Medical Supply Or Device Loan | $773.82 |
| Education | $198.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $808.14 | 2023-2024 | Acell, Integra, Primatrix |
| Incyte Corporation | $466.27 | 2023-2025 | Opzelura |
| Janssen Biotech, INC. | $315.73 | 2023-2025 | Tremfya |
| Lilly USA, LLC | $267.93 | 2023-2025 | Olumiant, Taltz, Ebglyss |
| Pfizer INC. | $212.09 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $175.32 | 2023-2024 | Sotyktu |
| Ucb, INC. | $168.94 | 2025 | Bimzelx |
| Genzyme Corporation | $160.64 | 2021-2024 | |
| Neurocrine Biosciences, INC. | $151.68 | 2025 | |
| Celgene Corporation | $124.70 | 2019 | |
| Abbvie INC. | $110.42 | 2023-2024 | Skyrizi |
| Polynovo North America LLC | $56.80 | 2023-2025 | Novosorb Btm |
| Arcutis Biotherapeutics, INC. | $36.90 | 2023-2025 | Zoryve |
| Leo Pharma INC. | $29.31 | 2025 | Anzupgo |
| Bausch & Lomb Americas INC. | $19.34 | 2024 | Xiidra, Miebo |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kyowa Kirin, INC. | $17.39 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sama Carley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.